Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences Inc (NQ: SAVA )

30.47 -0.00 (-0.00%)
Streaming Delayed Price Updated: 10:36 AM EDT, Sep 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 304,976
Open 30.90
Bid (Size) 30.43 (1)
Ask (Size) 30.50 (3)
Prev. Close 30.47
Today's Range 30.30 - 31.54
52wk Range 8.790 - 42.20
Shares Outstanding 41,969,994
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cassava Sciences Stock Rises On Interim Safety Review Of Simufilam Phase 3 Trials
Cassava Sciences, Inc. (NASDAQ: SAVA) shares trading higher following the announcement of a positive interim safety review of its Alzheimer's drug candidate, simufilam. Here's what you need to know. 
Via Benzinga
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
From Cassava Sciences, Inc.
Via GlobeNewswire

Performance

YTD
+35.90%
+35.90%
1 Month
+2.38%
+2.38%
3 Month
+64.16%
+64.16%
6 Month
+49.21%
+49.21%
1 Year
+78.49%
+78.49%

More News

Read More
Cassava Sciences Names Rick Barry as Chief Executive Officer
From Cassava Sciences, Inc.
Via GlobeNewswire
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
From Cassava Sciences, Inc.
Via GlobeNewswire
Here's How Much $100 Invested In Cassava Sciences 5 Years Ago Would Be Worth Today
Via Benzinga
Market Whales and Their Recent Bets on SAVA Options
Via Benzinga
9 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
Via MarketBeat
SAVA Stock Earnings: Cassava Sciences Beats EPS for Q2 2024
Via InvestorPlace
Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates
From Cassava Sciences, Inc.
Via GlobeNewswire
What's Going On With Cassava Sciences Today?
Via Benzinga
(SAVA) - Analyzing Cassava Sciences's Short Interest
Via Benzinga
What's Going On With Cassava Sciences Shares Today?
Via Benzinga
Cassava Sciences News: Why Is SAVA Stock Trending Today?
Via InvestorPlace
Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson
From Cassava Sciences, Inc.
Via GlobeNewswire
Cassava Sciences Shares Are Trading Higher Today: What You Need To Know
Via Benzinga
Get Your Money Out of These 3 Healthcare Stocks ASAP
Via InvestorPlace
8 Best-Performing Small Caps In July: Find Out Which Stock Jumped 803%
Via Benzinga
Cassava Sciences to Hold Conference Call to Discuss Recent Developments and Provide a Company Update on Thursday, August 8, 2024 at 8:30 am ET
From Cassava Sciences, Inc.
Via GlobeNewswire
Match Group Posts Upbeat Sales, Joins Modine Manufacturing, Scotts Miracle-Gro, NVIDIA And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
SmartRent (SMRT) Stock Plunges 21% as CEO Steps Down
Via InvestorPlace
Microsoft Office Outage: Microsoft Investigates Applications, Services Issue
Via InvestorPlace
SAVA Stock: Cassava Sciences Extends Simufilam Trials as Much as 36 Months
Via InvestorPlace
Cassava Sciences Announces Expansion of Open-Label Extension Trials
From Cassava Sciences, Inc.
Via GlobeNewswire
Get Your Money Out of These 3 Biotech Stocks Before the End of July
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.